JP2024530948A5 - - Google Patents
Info
- Publication number
- JP2024530948A5 JP2024530948A5 JP2024507146A JP2024507146A JP2024530948A5 JP 2024530948 A5 JP2024530948 A5 JP 2024530948A5 JP 2024507146 A JP2024507146 A JP 2024507146A JP 2024507146 A JP2024507146 A JP 2024507146A JP 2024530948 A5 JP2024530948 A5 JP 2024530948A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- compound according
- heterocycloalkyl
- nhc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163229858P | 2021-08-05 | 2021-08-05 | |
| US63/229,858 | 2021-08-05 | ||
| PCT/US2022/039466 WO2023014908A1 (en) | 2021-08-05 | 2022-08-04 | Lpar1 antagonists and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024530948A JP2024530948A (ja) | 2024-08-27 |
| JP2024530948A5 true JP2024530948A5 (https=) | 2025-06-13 |
Family
ID=85154801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024507146A Pending JP2024530948A (ja) | 2021-08-05 | 2022-08-04 | Ｌｐａｒ１アンタゴニスト及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250034110A1 (https=) |
| EP (1) | EP4380560A4 (https=) |
| JP (1) | JP2024530948A (https=) |
| KR (1) | KR20240046204A (https=) |
| CN (1) | CN118043041A (https=) |
| AU (1) | AU2022324465A1 (https=) |
| CA (1) | CA3228299A1 (https=) |
| CL (1) | CL2024000321A1 (https=) |
| IL (1) | IL310576A (https=) |
| MX (1) | MX2024001608A (https=) |
| WO (1) | WO2023014908A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026505038A (ja) * | 2023-01-27 | 2026-02-10 | コンティニューム・セラピューティクス・インコーポレイテッド | Ｌｐａｒ１アンタゴニストの結晶性化合物 |
| WO2025193711A1 (en) * | 2024-03-12 | 2025-09-18 | Contineum Therapeutics, Inc. | Peripherally restricted lpar1 antagonists and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849769A (en) * | 1994-08-24 | 1998-12-15 | Medivir Ab | N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection |
| US20050113283A1 (en) * | 2002-01-18 | 2005-05-26 | David Solow-Cordero | Methods of treating conditions associated with an EDG-4 receptor |
| US7820682B2 (en) * | 2002-10-03 | 2010-10-26 | Ono Pharmaceutical Co., Ltd. | LPA receptor antagonist |
| WO2009058921A1 (en) * | 2007-10-31 | 2009-05-07 | Smithkline Beecham Corporation | Ccr5 antagonists as therapeutic agents |
| PH12022550225A1 (en) * | 2019-07-30 | 2022-12-19 | Taisho Pharmaceutical Co Ltd | Urea compound for antagonizing lpa1 receptor |
-
2022
- 2022-08-04 AU AU2022324465A patent/AU2022324465A1/en active Pending
- 2022-08-04 WO PCT/US2022/039466 patent/WO2023014908A1/en not_active Ceased
- 2022-08-04 US US18/294,515 patent/US20250034110A1/en active Pending
- 2022-08-04 EP EP22853924.3A patent/EP4380560A4/en active Pending
- 2022-08-04 CN CN202280064596.4A patent/CN118043041A/zh active Pending
- 2022-08-04 CA CA3228299A patent/CA3228299A1/en active Pending
- 2022-08-04 IL IL310576A patent/IL310576A/en unknown
- 2022-08-04 KR KR1020247007354A patent/KR20240046204A/ko active Pending
- 2022-08-04 JP JP2024507146A patent/JP2024530948A/ja active Pending
- 2022-08-04 MX MX2024001608A patent/MX2024001608A/es unknown
-
2024
- 2024-02-01 CL CL2024000321A patent/CL2024000321A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024530948A5 (https=) | ||
| ES2658064T3 (es) | Moduladores de isoquinolina de transportadores de casete de unión a ATP | |
| ES2521672T3 (es) | Formulaciones farmacéuticas para el tratamiento del cáncer | |
| US7101887B2 (en) | 1-phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands | |
| ES2271464T3 (es) | Derivados de diazepan utiles como inhibidor del factor x. | |
| JP2001510843A5 (https=) | ||
| DK0734386T3 (da) | Blodpladeaktiveringsfaktor-antagonister:imidazopyridin-indoler | |
| EP0937459A3 (en) | Pharmaceutical compositions for the treatment of ischemic brain damage | |
| ATE39696T1 (de) | Cephalosporinderivate und verfahren zu ihrer herstellung. | |
| NO901571D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazoler. | |
| CA2409665A1 (en) | Novel composition | |
| IL117723A (en) | Indole-3-carbonyl and indole-3-sulfonyl derivatives platelet activating factor antagonist pharmaceutical compositions containing them and uses thereof | |
| SE0104332D0 (sv) | Therapeutic agents | |
| RU2004125279A (ru) | Новые пептиды, как ингибиторы ns3-серинпротеазы вируса гепатита c | |
| EA200900358A1 (ru) | Энантиомерно чистые фосфоиндолы в качестве ингибиторов hiv | |
| EP1566380A4 (en) | ISOCHINOLINE COMPOUNDS AND ITS MEDICAL USE | |
| CA2311669A1 (en) | (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties | |
| JP2007526257A5 (https=) | ||
| KR100376240B1 (ko) | 항바이러스제로서의4-(2-아미노-6-(시클로프로필아미노)-9h-푸린-9-일)-2-시클로펜텐-1-메탄올숙시네이트 | |
| PT2534150T (pt) | Métodos para tratar uma infecção viral | |
| EP0704215A3 (en) | Inhibitor of vascular permeability enhancer | |
| JP2018538354A5 (https=) | ||
| AR029178A1 (es) | Compuesto antagonista selectivo del receptor de adenosina a2b, composicion farmaceutica que los comprenden y el uso de los mismos para la manufactura de un medicamento | |
| JP2024542969A5 (https=) | ||
| SK276192A3 (en) | DIASTEREOMER OF 1-(ISOPROXYCARBONYLOXY)ETHYLESTER OF (6R,7R)-7-ì -£2-(2-AMINOTHIAZOL-4-YL)-2(Z)-METHOXYIMINO)ACETAMIDO|-3-ì -(METHOXYMETHYL)-3-CEFEM-4-CARBOXYLIC ACID, PREPARATION METHODì THEREOF, A PHARMACEUTICAL COMPOSITION AND USE |